Details for 2018785191

Up to date per 01.04.2026

Actions

Title / Product Name

NK1-ANTAGONISTENKOMBINATION UND VERFAHREN ZUR BEHANDLUNG VON SYNUKLEINOPATHIEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018785191

EP Publication Number

3609495

E-Number

1705667

Language

PCT Number

US18026699

Publication Date

19.02.2020 A

24.07.2024 B1

Registration Date

24.07.2024

AT Publication Date

15.08.2024

Application Date

09.04.2018

Registration Number

Priorities

10.04.2017

201762483555 P

IPC

A61K 31/675 20060101AFI20240130BHEP

Maximum Duration of Protection

09.04.2038

Owner

Chase Therapeutics Corporation1825 K Street N.W. Suite 520 Washington, DC 20006US

Representative

No representatives present

Inventor

CHASE, Thomas N.1825 K Street NW Suite 520 Washington, District of Columbia 20006US

CLARENCE-SMITH, Kathleen E.1825 K Street NW Suite 520 Washington, District of Columbia 20006US